Health

Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy

HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against durvalumab (PD-L1) combination the...

2025-09-02 16:00 1335

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL

 – establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable ingredients from natural sources, announced today the signing of a binding and definitive agreement to acquire the multipurpose production ...

2025-09-02 15:00 1658

Heartbeats: 230,000 Views for Dr. Kiat's Everyday Lunch - A Viral Lesson That Science Has No Borders

SYDNEY, Sept. 2, 2025 /PRNewswire/ -- A humble lunch video from world-renowned cardiologist Dr. Hosen Kiat has captured more than 230,000 views on Chinese social media Little Red Book. Shared as part of his new digital wellness initiative with Heartbeats, the "real-style" post featured nothing mo...

2025-09-02 10:08 1328

SteriLance Safety Lancets Adopted Across Thailand's Public-Hospital Channels

BANGKOK, Sept. 2, 2025 /PRNewswire/ -- SteriLance Medical announced that its safety lancet portfolio — PRESS PLUS, IMPRESS and LITE3 — has been adopted withinThailand's public-hospital channels following a tender awarded by a nationally recognized humanitarian organization. Supply and post-market...

2025-09-02 08:59 1806

LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company

Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships SEOUL, South Korea and SYRACUSE, N.Y., Sept. 2, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEOJames Park) today announced that it has entered a late-stage to commercial contract manufacturing par...

2025-09-02 08:00 1142

AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction

* AMI Pharm's 'AYP-101' Sets to Become a New Leader in Nonsurgical Fat Reduction with Phase 2 Trial Success * 'AYP-101,' a Promising Nonsurgical Solution, Has Its Clinical Results Published in Clinical Therapeutics * 'AYP-101' Demonstrates Superior Safety and Efficacy, Poised to Change the ...

2025-09-01 21:00 1438

Norma Completes Quantum AI Algorithm Validation on NVIDIA

"Quantum AI up to 73x Faster on NVIDIA CUDA-Q" * Norma, a quantum computing company, has validated the performance of quantum AI algorithms using NVIDIA CUDA-Q. * By running these algorithms for drug development on CUDA-Q, Norma observed computational speeds up to 73 times faster. * The com...

2025-09-01 21:00 1706

Introducing FitTransformer: The World's First Modular Smart Gym That Transforms Your Home Workouts

PHOENIX, Sept. 1, 2025 /PRNewswire/ -- Today marks the official launch of FitTransformer , a revolutionary fitness brand redefining how people train at home. Combining cutting-edge engineering, space-saving design, and intelligent performance tracking, FitTransformer ...

2025-09-01 16:00 1764

Data4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation

POTSDAM, Germany, Sept. 1, 2025 /PRNewswire/ -- Data4Life announces that the Hasso Plattner Foundation, as the supporting foundation of the organization, has appointed Dr. Ben Illigens as its new Chief Executive Officer (CEO). He succeedsChristian Weiss, who has shaped the development phase of D...

2025-09-01 16:00 2690

Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches

ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human study in 2019 followed by sustaining long-term results and a successful Randomized Contr...

2025-09-01 15:00 1350

Rosti to Showcase Next-Generation Medical Manufacturing Solutions at MedTec China 2025

SHANGHAI, Sept. 1, 2025 /PRNewswire/ -- Shanghai, September 24–26, 2025 – Stand 1D402 Rosti Integrated Manufacturing Solutions (Suzhou) Co., Ltd., part of the Rosti Group, will highlight its expanding medical device capabilities at MedTec China 2025, showcasing advanced medical injection mouldin...

2025-09-01 14:53 1581

CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry

GUANGZHOU, China, Sept. 1, 2025 /PRNewswire/ -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is set to take place from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) inGuangzhou. Themed "Health, Innovation, Collaboration," ...

2025-09-01 13:06 3865

Jenscare, releases 2025H1 interim results

BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 endedJune 30, 2025...

2025-09-01 13:00 4893

AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work

SINGAPORE, Sept. 1, 2025 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, has selected AbbVie for the2025 Best Workplaces in Asia™ List , ranking the company No. 7 up from No. 8 last year.

2025-09-01 09:00 1534

Jenscare Announces 2025H1 Interim Results

BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases, achieved key milestones in its product portfolio and just announced its interi...

2025-09-01 09:00 5661

The Veteran Suite partners with QENDO to advocate for female veteran care

SYDNEY, Sept. 1, 2025 /PRNewswire/ -- The Veteran Suite, a medical centre exclusively for Australian veterans and their families, has launched a new partnership with QENDO, an Australian organisation providing support and education for those affected by endometriosis, adenomyosis, PCOS, infertili...

2025-09-01 08:00 1331

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

HONG KONG, Aug. 30, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral ...

2025-08-30 01:07 5945

Jacobio Pharma Announces 2025 Interim Results

BEIJING and SHANGHAI and BOSTON, Aug. 29, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced its interim results for the six months endedJune 30, 2025. During the reporting period, the Company achieved revenue of RMB45.7 million, representing a 100% increase compared with the same per...

2025-08-30 00:25 4940

Lifezoom Updates: Refining Efficient Light Therapy Products Based on Customer Insights

NEW YORK, Aug. 29, 2025 /PRNewswire/ -- Since its launch, Lifezoom 's light therapy devices have steadily become a promising contender in the indu...

2025-08-29 23:21 1717

Guo Guangchang: Fosun Strives to Break Through in Advantageous Sectors and Reach the Global Pinnacle

HONG KONG, Aug. 29, 2025 /PRNewswire/ -- On the morning of 29 August, Guo Guangchang, Chairman of Fosun International, stated at the Company's 2025 interim results presentation that Fosun will continue to increase investment in biopharmaceuticals and focus on deepening and thoroughly developing i...

2025-08-29 20:13 3779
1 ... 55565758596061 ... 873

Week's Top Stories